188 related articles for article (PubMed ID: 34667092)
1. A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines.
Dardi F; Manes A; Guarino D; Zuffa E; De Lorenzis A; Magnani I; Rotunno M; Ballerini A; Lo Russo GV; Nardi E; Galiè N; Palazzini M
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34667092
[TBL] [Abstract][Full Text] [Related]
2. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension.
Chin KM; Rubin LJ; Channick R; Di Scala L; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Simonneau G; Sitbon O; Tapson VF
Circulation; 2019 May; 139(21):2440-2450. PubMed ID: 30982349
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the European Society of Cardiology Risk Assessment Score in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
Brown Z; Hansen D; Stevens W; Ferdowsi N; Ross L; Quinlivan A; Sahhar J; Ngian GS; Apostolopoulos D; Walker JG; Proudman S; Teng GG; Low AHL; Morrisroe K; Nikpour M
Arthritis Care Res (Hoboken); 2024 Jul; 76(7):973-983. PubMed ID: 38523256
[TBL] [Abstract][Full Text] [Related]
4. Guideline implementation and early risk assessment in pulmonary arterial hypertension associated with congenital heart disease: A retrospective cohort study.
Deng X; Jin B; Li S; Li Y; Zhou H; Wu Y; Yan M; Hu Y; Qiu Q; Zhang G; Zheng X
Clin Respir J; 2019 Nov; 13(11):693-699. PubMed ID: 31419027
[TBL] [Abstract][Full Text] [Related]
5. Single-center prognostic validation of the risk assessment of the 2015 ESC/ERS guidelines in patients with pulmonary arterial hypertension in Japan.
Imai R; Adachi S; Yoshida M; Shimokata S; Nakano Y; Okumura N; Murohara T; Kondo T
Can J Physiol Pharmacol; 2020 Sep; 98(9):653-658. PubMed ID: 32924564
[TBL] [Abstract][Full Text] [Related]
6. Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease.
Li X; Sun X; Huang Y; Wang Y; Yang X; Wang J; Zhang N; Gu L; Zhang M; Wang Q
Clin Rheumatol; 2019 Dec; 38(12):3619-3626. PubMed ID: 31385084
[TBL] [Abstract][Full Text] [Related]
7. Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry.
Frantz RP; Farber HW; Badesch DB; Elliott CG; Frost AE; McGoon MD; Zhao C; Mink DR; Selej M; Benza RL
Chest; 2018 Jul; 154(1):126-135. PubMed ID: 29355551
[TBL] [Abstract][Full Text] [Related]
8. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
9. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
Hoeper MM; Kramer T; Pan Z; Eichstaedt CA; Spiesshoefer J; Benjamin N; Olsson KM; Meyer K; Vizza CD; Vonk-Noordegraaf A; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Huscher D; Pittrow D; Rosenkranz S; Grünig E
Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28775047
[TBL] [Abstract][Full Text] [Related]
10. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.
Boucly A; Weatherald J; Savale L; Jaïs X; Cottin V; Prevot G; Picard F; de Groote P; Jevnikar M; Bergot E; Chaouat A; Chabanne C; Bourdin A; Parent F; Montani D; Simonneau G; Humbert M; Sitbon O
Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28775050
[TBL] [Abstract][Full Text] [Related]
11. Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients.
Delcroix M; Staehler G; Gall H; Grünig E; Held M; Halank M; Klose H; Vonk-Noordegraaf A; Rosenkranz S; Pepke-Zaba J; Opitz CF; Gibbs JSR; Lange TJ; Tsangaris I; Huscher D; Pittrow D; Olsson KM; Hoeper MM
Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30337446
[TBL] [Abstract][Full Text] [Related]
12. Risk assessment in pulmonary arterial hypertension: Insights from the GRIPHON study.
Sitbon O; Chin KM; Channick RN; Benza RL; Di Scala L; Gaine S; Ghofrani HA; Lang IM; McLaughlin VV; Preiss R; Rubin LJ; Simonneau G; Tapson VF; Galiè N; Hoeper MM
J Heart Lung Transplant; 2020 Apr; 39(4):300-309. PubMed ID: 32061506
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension.
Kylhammar D; Kjellström B; Hjalmarsson C; Jansson K; Nisell M; Söderberg S; Wikström G; Rådegran G
Eur Heart J; 2018 Dec; 39(47):4175-4181. PubMed ID: 28575277
[TBL] [Abstract][Full Text] [Related]
14. Mixed Venous Oxygen Saturation Is a Better Prognosticator Than Cardiac Index in Pulmonary Arterial Hypertension.
Khirfan G; Almoushref A; Naal T; Abuhalimeh B; Dweik RA; Heresi GA; Tonelli AR
Chest; 2020 Dec; 158(6):2546-2555. PubMed ID: 32629034
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of renal function in mortality risk assessment for pulmonary arterial hypertension.
Zelt JGE; Hossain A; Sun LY; Mehta S; Chandy G; Davies RA; Contreras-Dominguez V; Dunne R; Doyle-Cox C; Wells G; Stewart DJ; Mielniczuk LM
J Heart Lung Transplant; 2020 Jul; 39(7):675-685. PubMed ID: 32336606
[TBL] [Abstract][Full Text] [Related]
16. Mortality in Patients With Pulmonary Arterial Hypertension Treated With Continuous Prostanoids.
Bartolome SD; Sood N; Shah TG; Styrvoky K; Torres F; Chin KM
Chest; 2018 Sep; 154(3):532-540. PubMed ID: 29679599
[TBL] [Abstract][Full Text] [Related]
17. Congenital heart disease with pulmonary artery hypertension in an Asian cohort-initial report from TACHYON (TAiwan congenital heart disease associated with pulmonarY arterial hypertension) registry.
Chiu SN; Weng KP; Lin MC; Wang JN; Hwang BT; Dai ZK; Lin SM; Chang JS; Lin IC; Wu MH; Lu CW; Lin MT; Chen CA; Hua YC; Wu JM; Wang JK;
Int J Cardiol; 2020 Oct; 317():49-55. PubMed ID: 32522677
[TBL] [Abstract][Full Text] [Related]
18. Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines.
Distler O; Bonderman D; Coghlan JG; Denton CP; Grünig E; Khanna D; McLaughlin VV; Müller-Ladner U; Pope JE; Vonk MC; Di Scala L; Lemarie JC; Perchenet L; Hachulla É
Arthritis Rheumatol; 2024 May; 76(5):777-782. PubMed ID: 38146100
[TBL] [Abstract][Full Text] [Related]
19. External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry.
Boucly A; Weatherald J; Savale L; de Groote P; Cottin V; Prévot G; Chaouat A; Picard F; Horeau-Langlard D; Bourdin A; Jutant EM; Beurnier A; Jevnikar M; Jaïs X; Simonneau G; Montani D; Sitbon O; Humbert M
Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34737227
[TBL] [Abstract][Full Text] [Related]
20. COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension.
Hoeper MM; Pausch C; Olsson KM; Huscher D; Pittrow D; Grünig E; Staehler G; Vizza CD; Gall H; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Park DH; Ewert R; Kaemmerer H; Kabitz HJ; Skowasch D; Behr J; Milger K; Halank M; Wilkens H; Seyfarth HJ; Held M; Dumitrescu D; Tsangaris I; Vonk-Noordegraaf A; Ulrich S; Klose H; Claussen M; Lange TJ; Rosenkranz S
Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34737226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
